| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
110.25(B) |
| Last
Volume: |
6,013,077 |
Avg
Vol: |
8,376,873 |
| 52
Week Range: |
$48.64 - $77.42 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
304,513 |
503,645 |
996,293 |
2,118,674 |
| Total Sell Value |
$22,679,618 |
$34,760,114 |
$60,765,476 |
$110,963,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
26 |
43 |
79 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Abele John E |
Director |
– • – |
2009-01-05 |
4 |
AS |
$7.70 |
$770,000 |
D/D |
(100,000) |
32,483,029 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2009-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
588 |
9,823 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-02 |
4 |
AS |
$7.75 |
$775,100 |
I/I |
(100,000) |
18,330,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-01-02 |
4 |
AS |
$7.75 |
$775,100 |
D/D |
(100,000) |
32,583,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-12-31 |
4 |
AS |
$7.60 |
$759,700 |
I/I |
(100,000) |
18,430,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2008-12-31 |
4 |
AS |
$7.60 |
$759,700 |
D/D |
(100,000) |
32,683,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-12-30 |
4 |
AS |
$7.34 |
$734,100 |
I/I |
(100,000) |
18,530,032 |
|
- |
|
| Mario Ernest |
Director |
– • – |
2008-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,200 |
85,604 |
|
- |
|
| Abele John E |
Director |
– • – |
2008-12-30 |
4 |
AS |
$7.34 |
$734,100 |
D/D |
(100,000) |
32,783,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-12-29 |
4 |
AS |
$7.33 |
$733,200 |
I/I |
(100,000) |
18,630,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2008-12-29 |
4 |
AS |
$7.33 |
$733,200 |
D/D |
(100,000) |
32,883,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-12-26 |
4 |
AS |
$7.38 |
$737,700 |
I/I |
(100,000) |
18,730,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2008-12-26 |
4 |
AS |
$7.38 |
$737,700 |
D/D |
(100,000) |
32,983,029 |
|
- |
|
| Abele John E |
Director |
– • – |
2008-12-24 |
4 |
AS |
$7.38 |
$738,000 |
D/D |
(100,000) |
33,083,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-12-24 |
4 |
AS |
$7.38 |
$738,000 |
I/I |
(100,000) |
18,830,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2008-12-23 |
4 |
AS |
$7.48 |
$748,400 |
D/D |
(100,000) |
33,183,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-12-23 |
4 |
AS |
$7.48 |
$748,400 |
I/I |
(100,000) |
18,930,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2008-12-22 |
4 |
AS |
$7.51 |
$751,300 |
D/D |
(100,000) |
33,283,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-12-22 |
4 |
AS |
$7.51 |
$751,300 |
I/I |
(100,000) |
19,030,032 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-12-22 |
4/A |
AS |
$7.51 |
$751,300 |
I/I |
(100,000) |
19,030,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2008-12-22 |
4/A |
AS |
$7.51 |
$751,300 |
D/D |
(100,000) |
33,283,029 |
|
- |
|
| Abele John E |
Director |
– • – |
2008-12-19 |
4 |
AS |
$7.80 |
$779,600 |
D/D |
(100,000) |
33,383,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-12-19 |
4 |
AS |
$7.80 |
$779,600 |
I/I |
(100,000) |
19,130,032 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2008-12-19 |
4/A |
AS |
$7.80 |
$779,600 |
I/I |
(100,000) |
19,130,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2008-12-19 |
4/A |
AS |
$7.80 |
$779,600 |
D/D |
(100,000) |
33,383,029 |
|
- |
|
1823 Records found
|
|
Page 59 of 73 |
|
|
0.41 (0.53%) 
